Crystallography and the design of anti-AIDS drugs: conformational flexibility and positional adaptability are important in the design of non-nucleoside HIV-1 reverse transcriptase inhibitors

作者: Kalyan Das , Paul J. Lewi , Stephen H. Hughes , Eddy Arnold

DOI: 10.1016/J.PBIOMOLBIO.2004.07.001

关键词:

摘要: Drug resistance is a key cause of failure for treatment HIV infection. The efficacy non-nucleoside reverse transcriptase inhibiting (NNRTI) drugs impaired by rapid emergence drug-resistance mutations. A multidisciplinary effort led to the discovery potent NNRTIs dapivirine and etravirine, both which are diarylpyrimidine (DAPY) derivatives. Systematic structural molecular modeling studies HIV-1 (RT)/NNRTI complexes revealed different modes inhibitor binding, some DAPY inhibitors can bind RT in conformations. torsional flexibility ("wiggling") generate numerous conformational variants compactness permits significant repositioning reorientation (translation rotation) within pocket ("jiggling"). Such adaptations appear be critical ability retain their potency against wide range drug-resistant RTs. Exploitation (such as about strategically located chemical bonds) powerful element drug design, especially design that will effective rapidly mutating targets (which collection related targets).

参考文章(62)
Chris Tantillo, Jianping Ding, Alfredo Jacobo-Molina, Raymond G. Nanni, Paul L. Boyer, Stephen H. Hughes, Rudi Pauwels, Koen Andries, Paul A.J. Janssen, Edward Arnold, Locations of anti-AIDS drug binding sites and resistance mutations in the three-dimensional structure of HIV-1 reverse transcriptase. Implications for mechanisms of drug inhibition and resistance Journal of Molecular Biology. ,vol. 243, pp. 369- 387 ,(1994) , 10.1006/JMBI.1994.1665
K. Van Vaerenbergh, T. Harrer, J.-C. Schmit, A. Carbonez, E. Fontaine, M. Kurowski, M. Grünke, P. Löw, A. Rascu, B. Schmidt, M. Schmitt, I. Thoelen, H. Walter, K. Van Laethem, M. Van Ranst, J. Desmyter, E. De Clercq, A.-M. Vandamme, Initiation of HAART in drug-naive HIV type 1 patients prevents viral breakthrough for a median period of 35.5 months in 60% of the patients. AIDS Research and Human Retroviruses. ,vol. 18, pp. 419- 426 ,(2002) , 10.1089/088922202753614182
Xiping Wei, Sajal K. Ghosh, Maria E. Taylor, Victoria A. Johnson, Emilio A. Emini, Paul Deutsch, Jeffrey D. Lifson, Sebastian Bonhoeffer, Martin A. Nowak, Beatrice H. Hahn, Michael S. Saag, George M. Shaw, Viral dynamics in human immunodeficiency virus type 1 infection Nature. ,vol. 373, pp. 117- 122 ,(1995) , 10.1038/373117A0
Huifang Huang, Rajiv Chopra, Gregory L Verdine, Stephen C Harrison, Structure of a Covalently Trapped Catalytic Complex of HIV-1 Reverse Transcriptase: Implications for Drug Resistance Science. ,vol. 282, pp. 1669- 1675 ,(1998) , 10.1126/SCIENCE.282.5394.1669
Marita Högberg, Christer Sahlberg, Per Engelhardt, Rolf Noréen, Jussi Kangasmetsä, Nils Gunnar Johansson, Bo Öberg, Lotta Vrang, Hong Zhang, Britt-Louise Sahlberg, Torsten Unge, Seved Lövgren, Kerstin Fridborg, Kristina Bäckbro, Urea-PETT compounds as a new class of HIV-1 reverse transcriptase inhibitors. 3. Synthesis and further structure-activity relationship studies of PETT analogues. Journal of Medicinal Chemistry. ,vol. 42, pp. 4150- 4160 ,(1999) , 10.1021/JM990095J
Jianping Ding, Kalyan Das, Henri Moereels, Luc Koymans, Koen Andries, Paul A.J. Janssen, Stepen H. Hughes, Edward Arnold, Structure of HIV-1 RT/TIBO R 86183 complex reveals similarity in the binding of diverse nonnucleoside inhibitors Nature Structural & Molecular Biology. ,vol. 2, pp. 407- 415 ,(1995) , 10.1038/NSB0595-407
C. K. Shih, J. M. Rose, G. L. Hansen, J. C. Wu, A. Bacolla, J. A. Griffin, Chimeric human immunodeficiency virus type 1/type 2 reverse transcriptases display reversed sensitivity to nonnucleoside analog inhibitors. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 88, pp. 9878- 9882 ,(1991) , 10.1073/PNAS.88.21.9878
J. Cohen, THERAPIES: Raising the Limits Science. ,vol. 296, pp. 2322- 2322 ,(2002) , 10.1126/SCIENCE.296.5577.2322
L. Kohlstaedt, J Wang, J. Friedman, P. Rice, T. Steitz, Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor. Science. ,vol. 256, pp. 1783- 1790 ,(1992) , 10.1126/SCIENCE.1377403